Hyperpolarized [13C] Pyruvate imaging agent

pyruvate (hyperpolarized carbon-13)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hyperpolarized [13C] Pyruvate imaging agent, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection [Phase 1]